Treace Selling General Administrative from 2010 to 2025

TMCI Stock  USD 9.61  0.02  0.21%   
Treace Medical's Selling General Administrative is increasing with slightly volatile movements from year to year. Selling General Administrative is estimated to finish at about 56.8 M this year. For the period between 2010 and 2025, Treace Medical, Selling General Administrative quarterly trend regression had mean deviation of  15,990,769 and range of 52.3 M. View All Fundamentals
 
Selling General Administrative  
First Reported
2010-12-31
Previous Quarter
54.1 M
Current Value
56.8 M
Quarterly Volatility
19.6 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Treace Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Treace Medical's main balance sheet or income statement drivers, such as Net Interest Income of 233 K, Interest Income of 6.5 M or Depreciation And Amortization of 6.5 M, as well as many indicators such as Price To Sales Ratio of 4.53, Dividend Yield of 0.0 or PTB Ratio of 6.15. Treace financial statements analysis is a perfect complement when working with Treace Medical Valuation or Volatility modules.
  
Check out the analysis of Treace Medical Correlation against competitors.

Latest Treace Medical's Selling General Administrative Growth Pattern

Below is the plot of the Selling General Administrative of Treace Medical Concepts over the last few years. It is Treace Medical's Selling General Administrative historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Treace Medical's overall financial position and show how it may be relating to other accounts over time.
Selling General Administrative10 Years Trend
Slightly volatile
   Selling General Administrative   
       Timeline  

Treace Selling General Administrative Regression Statistics

Arithmetic Mean16,282,286
Geometric Mean8,985,355
Coefficient Of Variation120.68
Mean Deviation15,990,769
Median4,464,000
Standard Deviation19,648,863
Sample Variance386.1T
Range52.3M
R-Value0.81
Mean Square Error144.6T
R-Squared0.65
Significance0.0002
Slope3,328,196
Total Sum of Squares5791.2T

Treace Selling General Administrative History

202556.8 M
202454.1 M
202347 M
202233 M
202118.4 M
20206.5 M

About Treace Medical Financial Statements

Investors use fundamental indicators, such as Treace Medical's Selling General Administrative, to determine how well the company is positioned to perform in the future. Although Treace Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Selling General Administrative54.1 M56.8 M

Currently Active Assets on Macroaxis

When determining whether Treace Medical Concepts offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Treace Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Treace Medical Concepts Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Treace Medical Concepts Stock:
Check out the analysis of Treace Medical Correlation against competitors.
You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Treace Medical. If investors know Treace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Treace Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.99)
Revenue Per Share
3.274
Quarterly Revenue Growth
0.106
Return On Assets
(0.17)
Return On Equity
(0.51)
The market value of Treace Medical Concepts is measured differently than its book value, which is the value of Treace that is recorded on the company's balance sheet. Investors also form their own opinion of Treace Medical's value that differs from its market value or its book value, called intrinsic value, which is Treace Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Treace Medical's market value can be influenced by many factors that don't directly affect Treace Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Treace Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Treace Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Treace Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.